A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03516266
Collaborator
Liuzhou Maternity and Child Healthcare Hospital (Other), Qingdao Municipal Hospital (Other), Zhongshan City People's Hospital (Other), The First Affiliated Hospital with Nanjing Medical University (Other), Second Affiliated Hospital of Soochow University (Other), Maternity and Child Health Hospital of Changsha (Other), Henan Provincial People's Hospital (Other), Huaian Maternal and Child Health Care Hospital (Other), Hunan Provincial Maternal and Child Health Care Hospital (Other), Fourth Hospital of Shijiazhuang City (Other), Shenzhen Luohu District Maternity And Child Healthcare Hospital (Other), Second Affiliated Hospital of Wenzhou Medical University (Other), Hubei Shiyan People's Hospital (Other), Changzhi Maternity & Child Health Hospital (Other), Maternal and Child Health Care Hospital of Xinjiang Uygur Autonomous Region (Other), The First Hospital of Hebei Medical University (Other), Shen-Zhen City Maternity and Child Healthcare Hospital (Other), Dalian Medical University (Other), Maternity and Child Care Center of QinHuangDao City (Other), The People's Hospital of Leshan (Other)
7,920
1
31.7
249.5

Study Details

Study Description

Brief Summary

This study aims to investigate the status of pelvic floor function of healthy female in China, including premenopausal nullipara, premenopausal women with childbirth and postmenopausal women.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a cross-sectional survey. The normal physical examination population is divided into three groups,including premenopausal nullipara, premenopausal women with childbirth and postmenopausal women. The pelvic floor muscle function in three groups are evaluated. The modified Oxford Grading Scale and Levator ani testing is used to quantify PFM strength through vaginal palpation. Pelvic floor muscle strength ,endurance, repetition,vaginal contraction pressure and the knack test are evaluated using a PHENIX USB 8 neuromuscular stimulation therapy system (Company: Vivaltis-Electronic Concept Lignon Innovation, Montpellier, France). In six different regions of China according to geographic region (northwest, southwest, north, east, northeast, and central-south China) , 1 or more hospitals in each area are selected as sub-centers, which needs to complete the evaluation of pelvic floor muscle function of 360 cases in 3 groups totally.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    7920 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female
    Actual Study Start Date :
    May 10, 2018
    Anticipated Primary Completion Date :
    Dec 31, 2020
    Anticipated Study Completion Date :
    Dec 31, 2020

    Outcome Measures

    Primary Outcome Measures

    1. maximum vaginal contraction pressure [1 day]

      it is measured by manometry, range(80-150cmH2O). The higher values represent better outcomes.

    Secondary Outcome Measures

    1. Pelvic floor muscle strength [1 day]

      The modified Oxford Grading Scale is used to quantify PFM strength through vaginal palpation. range(0-5).The higher values represent better outcomes. through vaginal palpation.

    2. Pelvic floor muscle strength(repetition) [1 day]

      Levator ani testing is used to quantify PFM strength. range(0-5). The higher values represent better outcomes.

    3. Pelvic floor muscle contraction endurance [1 day]

      muscle contractions maintained for 0 s are defined as grade 0, 1 s as grade I, 2 s as grade II, 3 s as grade III, 4 s as grade IV, and 5 s or longer as grade V. Normal muscles can maintain the contraction for 5 s. range(0-5s). The higher values represent better outcomes.

    4. pelvic organ prolapse quantification [1 day]

      POP-Q is measured when maximum valsalva. range(0-4). stage 0 represents normal.

    5. the knack test [1 day]

      a voluntary PFM contraction before or during coughing. That the contraction could be performed represents normal.

    6. vaginal rest pressure [1 day]

      measure when no vaginal contraction by manometry. range(25-50 cmH2O). the lower and the higher values represent abnormal outcomes.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    Group A:Premenopausal women without history of abortion or delivery

    1. Having sex life and tolerable to vaginal examination

    2. Premenopausal women without history of abortion over 16 weeks

    3. Premenopausal women without history of childbirth

    4. Planning to live locally for a long time

    Group B:Premenopausal women with childbirth

    1. Having sex life and tolerable to vaginal examination

    2. Premenopausal women with childbirth (including cesarean section or natural birth).

    3. Planning to live locally for a long time

    Group C:Postmenopausal women (over a year, except surgical menopause)

    1. Having sex life and tolerable to vaginal examination

    2. Postmenopausal women

    3. Planning to live locally for a long time

    Exclusion Criteria:
    1. Incontinence 4 weeks before enrollment

    2. History of fecal incontinence

    3. Prolapse beyond the level of the hymen

    4. History of radical operation of pelvic cavity(cervical cancer,rectal cancer,bladder cancer, ect)

    5. History of pelvic radiotherapy

    6. History of pelvic floor surgery

    7. History of abortion over 16 weeks' pregnancy or in 1 year after delivery

    8. Duration of pregnancy

    9. Duration of lactation

    10. History of hysterectomy

    11. Latex allergy

    12. Colpitis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences Beijing Beiing China 100730

    Sponsors and Collaborators

    • Peking Union Medical College Hospital
    • Liuzhou Maternity and Child Healthcare Hospital
    • Qingdao Municipal Hospital
    • Zhongshan City People's Hospital
    • The First Affiliated Hospital with Nanjing Medical University
    • Second Affiliated Hospital of Soochow University
    • Maternity and Child Health Hospital of Changsha
    • Henan Provincial People's Hospital
    • Huaian Maternal and Child Health Care Hospital
    • Hunan Provincial Maternal and Child Health Care Hospital
    • Fourth Hospital of Shijiazhuang City
    • Shenzhen Luohu District Maternity And Child Healthcare Hospital
    • Second Affiliated Hospital of Wenzhou Medical University
    • Hubei Shiyan People's Hospital
    • Changzhi Maternity & Child Health Hospital
    • Maternal and Child Health Care Hospital of Xinjiang Uygur Autonomous Region
    • The First Hospital of Hebei Medical University
    • Shen-Zhen City Maternity and Child Healthcare Hospital
    • Dalian Medical University
    • Maternity and Child Care Center of QinHuangDao City
    • The People's Hospital of Leshan

    Investigators

    • Principal Investigator: Lan Zhu, MD, Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Peking Union Medical College Hospital
    ClinicalTrials.gov Identifier:
    NCT03516266
    Other Study ID Numbers:
    • JS-1550
    First Posted:
    May 4, 2018
    Last Update Posted:
    May 11, 2018
    Last Verified:
    Apr 1, 2018
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Peking Union Medical College Hospital

    Study Results

    No Results Posted as of May 11, 2018